Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence

Accurate methods for cross-sectional incidence estimation are needed for HIV prevention research. The Limiting Antigen Avidity (LAg-Avidity) assay has been marketed by two vendors, Maxim Biomedical and Sedia BioSciences Corporation. Performance differences between the two versions of the assay are u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Schlusser, Katherine E., Konikoff, Jacob, Kirkpatrick, Allison R., Morrison, Charles, Chipato, Tsungai, Chen, Pai-Lien, Munjoma, Marshall, Eshleman, Susan H., Laeyendecker, Oliver
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467096/
https://ncbi.nlm.nih.gov/pubmed/28318310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados